GHDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Genomic Health Inc's other long-term assets for the quarter that ended in Sep. 2014 was $16.0 Mil.
Genomic Health Inc's quarterly other long-term assets declined from Mar. 2014 ($15.4 Mil) to Jun. 2014 ($14.1 Mil) but then increased from Jun. 2014 ($14.1 Mil) to Sep. 2014 ($16.0 Mil).
Genomic Health Inc's annual other long-term assets increased from Dec. 2011 ($4.6 Mil) to Dec. 2012 ($9.4 Mil) and increased from Dec. 2012 ($9.4 Mil) to Dec. 2013 ($13.8 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
Genomic Health Inc Annual Data
|Other Long-Term Assets||0.2||0.7||0.9||1.0||0.9||1.0||2.9||4.6||9.4||13.8|
Genomic Health Inc Quarterly Data
|Other Long-Term Assets||6.2||6.6||9.4||9.5||9.5||9.5||13.8||15.4||14.1||16.0|